OBJECTIVE: Investigations of the combined effects of neoadjuvant Onyx embolization and stereotactic radiosurgery (SRS) on brain arteriovenous malformations (AVMs) have not accounted for initial angioarchitectural features prior to neuroendovascular intervention. The aim of this retrospective, multicenter matched cohort study is to compare the outcomes of SRS with versus without upfront Onyx embolization for AVMs using de novo characteristics of the preembolized nidus. METHODS: The International Radiosurgery Research Foundation AVM databases from 1987 to 2018 were retrospectively reviewed. Patients were categorized based on AVM treatment approach into Onyx embolization (OE) and SRS (OE+SRS) or SRS alone (SRS-only) cohorts and then propensity score matched in a 1:1 ratio. The primary outcome was AVM obliteration. Secondary outcomes were post-SRS hemorrhage, all-cause mortality, radiological and symptomatic radiation-induced changes (RICs), and cyst formation. Comparisons were analyzed using crude rates and cumulative probabilities adjusted for competing risk of death. RESULTS: The matched OE+SRS and SRS-only cohorts each comprised 53 patients. Crude rates (37.7% vs 47.2% for the OE+SRS vs SRS-only cohorts, respectively; OR 0.679, p = 0.327) and cumulative probabilities at 3, 4, 5, and 6 years (33.7%, 44.1%, 57.5%, and 65.7% for the OE+SRS cohort vs 34.8%, 45.5%, 59.0%, and 67.1% for the SRS-only cohort, respectively; subhazard ratio 0.961, p = 0.896) of AVM obliteration were similar between the matched cohorts. The secondary outcomes of the matched cohorts were also similar. Asymptomatic and symptomatic embolization-related complication rates in the matched OE+SRS cohort were 18.9% and 9.4%, respectively. CONCLUSIONS: Pre-SRS AVM embolization with Onyx does not appear to negatively influence outcomes after SRS. These analyses, based on de novo nidal characteristics, thereby refute previous studies that found detrimental effects of Onyx embolization on SRS-induced AVM obliteration. However, given the risks incurred by nidal embolization using Onyx, this neoadjuvant intervention should be used judiciously in multimodal treatment strategies involving SRS for appropriately selected large-volume or angioarchitecturally high-risk AVMs.

Department of Neurological Surgery University of Virginia Charlottesville Virginia

Department of Neurosurgery Na Homolce Hospital Prague Czech Republic

Department of Neurosurgery New York University New York New York

Department of Neurosurgery Taipei Veterans General Hospital Taipei Taiwan

Department of Neurosurgery The Jewish Hospital Cincinnati Ohio

Department of Neurosurgery University of Pennsylvania Philadelphia Pennsylvania

Department of Neurosurgery University of Puerto Rico San Juan Puerto Rico

Department of Neurosurgery University of Sherbrooke Canada

Department of Neurosurgery West Virginia University Morgantown West Virginia

Department of Radiation Oncology The Mayo Clinic Jacksonville Florida

Departments of12Neurosurgery and

Departments of2Neurosurgery and

Radiation Oncology Pennsylvania State University Hershey Pennsylvania; and

Radiation Oncology University of Louisville Kentucky

Zobrazit více v PubMed

Kano H, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations, Part 6: Multistaged volumetric management of large arteriovenous malformations. J Neurosurg. 2012; 116(1): 54–65. PubMed

Ilyas A, Chen CJ, Ding D, et al. Volume-staged versus dose-staged stereotactic radiosurgery outcomes for large brain arteriovenous malformations: a systematic review. J Neurosurg. 2018; 128(1): 154–164. PubMed

Patibandla MR, Ding D, Kano H, et al. Stereotactic radiosurgery for Spetzler-Martin Grade IV and V arteriovenous malformations: an international multicenter study. J Neurosurg. 2018; 129(2): 498–507. PubMed

Solomon RA, Connolly ES Jr. Arteriovenous malformations of the brain. N Engl J Med. 2017; 376(19): 1859–1866. PubMed

Kano H, Kondziolka D, Flickinger JC, et al. Aneurysms increase the risk of rebleeding after stereotactic radiosurgery for hemorrhagic arteriovenous malformations. Stroke. 2012; 43(10): 2586–2591. PubMed

Ding D, Ilyas A, Sheehan JP. Contemporary management of high-grade brain arteriovenous malformations. Neurosurgery. 2018; 65(CN_suppl_1): 24–33. PubMed

Russell D, Peck T, Ding D, et al. Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: a systematic review and meta-analysis. J Neurosurg. 2018; 128(5): 1338–1348. PubMed

Lee CC, Chen CJ, Ball B, et al. Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study. J Neurosurg. 2015; 123(1): 126–135. PubMed

Andrade-Souza YM, Ramani M, Beachey DJ, et al. Liquid embolisation material reduces the delivered radiation dose: a physical experiment. Acta Neurochir (Wien). 2008; 150(2): 161–164. PubMed

Kano H, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations after embolization: a case-control study. J Neurosurg. 2012; 117(2): 265–275. PubMed

Oermann EK, Ding D, Yen CP, et al. Effect of prior embolization on cerebral arteriovenous malformation radiosurgery outcomes: a case-control study. Neurosurgery. 2015; 77(3): 406–417. PubMed

Andrade-Souza YM, Ramani M, Scora D, et al. Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations. Neurosurgery. 2007; 60(3): 443–452. PubMed

Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996; 27(8): 1304–1305. PubMed

Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986; 65(4): 476–483. PubMed

Wegner RE, Oysul K, Pollock BE, et al. A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys. 2011; 79(4): 1147–1150. PubMed

Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. 2003. Statistical Software Components. Accessed September 1, 2020. http://ideas.repec.org/c/boc/bocode/s432001.html

Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94(446): 496–509.

Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016; 133(6): 601–609. PubMed PMC

Roberts DA, Balter JM, Chaudhary N, et al. Dosimetric measurements of Onyx embolization material for stereotactic radiosurgery. Med Phys. 2012; 39(11): 6672–6681. PubMed

Valle RD, Zenteno M, Jaramillo J, et al. Definition of the key target volume in radiosurgical management of arteriovenous malformations: a new dynamic concept based on angiographic circulation time. J Neurosurg. 2008; 109(suppl): 41–50. PubMed

Pollock BE, Kondziolka D, Lunsford LD, et al. Repeat stereotactic radiosurgery of arteriovenous malformations: factors associated with incomplete obliteration. Neurosurgery. 1996; 38(2): 318–324. PubMed

Akakin A, Ozkan A, Akgun E, et al. Endovascular treatment increases but gamma knife radiosurgery decreases angiogenic activity of arteriovenous malformations: an in vivo experimental study using a rat cornea model. Neurosurgery. 2010; 66(1): 121–130. PubMed

Buell TJ, Ding D, Starke RM, et al. Embolization-induced angiogenesis in cerebral arteriovenous malformations. J Clin Neurosci. 2014; 21(11): 1866–1871. PubMed

Fournier D, Terbrugge K, Rodesch G, Lasjaunias P. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology. 1990; 32(6): 497–501. PubMed

Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg. 1996; 85(1): 19–28. PubMed

Rao VR, Mandalam KR, Gupta AK, et al. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up. AJNR Am J Neuroradiol. 1989; 10(1): 135–141. PubMed PMC

Bing F, Doucet R, Lacroix F, et al. Liquid embolization material reduces the delivered radiation dose: clinical myth or reality? AJNR Am J Neuroradiol. 2012; 33(2): 320–322. PubMed PMC

Mamalui-Hunter M, Jiang T, Rich KM, et al. Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article. J Neurosurg. 2011; 115(2): 364–370. PubMed

Watanabe Y, Sandhu D, Warmington L, et al. Three-dimensional assessment of the effects of high-density embolization material on the absorbed dose in the target for Gamma Knife radiosurgery of arteriovenous malformations. J Neurosurg. 2016; 125(1)(suppl 1): 123–128. PubMed

Schlesinger DJ, Nordström H, Lundin A, et al. Dosimetric effects of Onyx embolization on Gamma Knife arteriovenous malformation dose distributions. J Neurosurg. 2016; 125(1) (suppl 1): 114–122. PubMed

Starke RM, Kano H, Ding D, et al. Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort. J Neurosurg. 2017; 126(1): 36–44. PubMed

Chen CJ, Lee CC, Ding D, et al. Stereotactic radiosurgery for unruptured versus ruptured pediatric brain arteriovenous malformations. Stroke. 2019; 50(10): 2745–2751. PubMed

Ding D, Yen CP, Starke RM, et al. Effect of prior hemorrhage on intracranial arteriovenous malformation radiosurgery outcomes. Cerebrovasc Dis. 2015; 39(1): 53–62. PubMed

Chen CJ, Ding D, Kano H, et al. Effect of advanced age on stereotactic radiosurgery outcomes for brain arteriovenous malformations: a multicenter matched cohort study. World Neurosurg. 2018; 119: e429–e440. PubMed

Chen CJ, Ding D, Kano H, et al. Stereotactic radiosurgery for pediatric versus adult brain arteriovenous malformations. Stroke. 2018; 49(8): 1939–1945. PubMed

Seymour ZA, Chan JW, Sneed PK, et al. Dose response and architecture in volume staged radiosurgery for large arteriovenous malformations: a multi-institutional study. Radiother Oncol. 2020; 144: 180–188. PubMed

Ding D, Chen CJ, Starke RM, et al. Risk of brain arteriovenous malformation hemorrhage before and after stereotactic radiosurgery. Stroke. 2019; 50(6): 1384–1391. PubMed

Taeshineetanakul P, Krings T, Geibprasert S, et al. Angio-architecture determines obliteration rate after radiosurgery in brain arteriovenous malformations. Neurosurgery. 2012; 71(6): 1071–1079. PubMed

Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD. A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys. 1996; 36(4): 873–879. PubMed

Roark C, Vadlamudi V, Chaudhary N, et al. ABC/2 method does not accurately predict cerebral arteriovenous malformation volume. Neurosurgery. 2018; 82(2): 220–225. PubMed

Webb AJ, Ullman NL, Morgan TC, et al. Accuracy of the ABC/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke. 2015; 46(9): 2470–2476. PubMed PMC

Lee CC, Reardon MA, Ball BZ, et al. The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery. J Neurosurg. 2015; 123(1): 136–144. PubMed